# The BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR)

> **NCT02521181** · PHASE3 · COMPLETED · sponsor: **Jennifer Gassman, PhD** · enrollment: 194 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Lower Dose Sodium Bicarbonate
- **DRUG:** Higher Dose Sodium Bicarbonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02521181
- **Lead sponsor:** Jennifer Gassman, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2018-01
- **Final completion:** 2018-06
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2020-10-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02521181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02521181, "The BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02521181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*